NeuroMetrix of out of Waltham, MA received FDA clearance for its SENSUS Pain Management System to be used by patients during sleep. This is the first transcutaneous electrical nerve stimulation system to receive a sleep indication from the FDA for pain control.
The device is designed for use by diabetics and others with chronic pain in the legs and feet. It’s worn around one or both legs and delivers an electrical current to disrupt pain signals being sent up to the brain. Last year we had a chance to speak with Shai N. Gozani, the CEO of NeuroMetrix who discussed the company’s technology and plans for the future.